Invest now
Nectar Lifesciences Key Metrics
BSE: 532649 | NSE: NECLIFE | ISIN: INE023H01027 | Sector: Biotechnology & Drugs10.15 +0.02 (0.20%)Updated : 12 Oct 2026
Research on
Ratios
| Return on average equity - 5 year average | -1.02 |
| Net Income/employee - trailing 12 month | -66,47,334.00 |
| Revenue/employee - most recent fiscal year | 21,201.90 |
| Return on investment - most recent fiscal year | -7.07 |
| Return on average assets - most recent fiscal year | -4.30 |
| Receivables turnover - most recent fiscal year | 0.01 |
| Return on investment - trailing 12 month | 0.00 |
| Return on average assets - trailing 12 month | 0.00 |
| Inventory turnover - most recent fiscal year | 0.00 |
| Inventory turnover - trailing 12 month | 0.00 |
| Revenue/employee - trailing 12 month | 6,70,576.60 |
| Return on average assets - 5 year average | -0.49 |
| Net Income/employee - most recent fiscal year | -6,04,607.30 |
| Return on average equity - trailing 12 month | 0.00 |
| Receivables turnover - trailing 12 month | 0.00 |
| Asset turnover - most recent fiscal year | 0.00 |
| Asset turnover - trailing 12 month | 0.00 |
| Return on average equity - most recent fiscal year | -7.46 |
| Return on investment - 5 year average | -0.87 |
Nectar Lifesciences Quick Links
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Shareholdings Nectar Lifesciences Profit Loss Nectar Lifesciences Balance Sheet Nectar Lifesciences Cashflow Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,035.00+40.00(4.02%)
2,079.30+29.30(1.43%)
1,246.00+17.00(1.38%)
11,400.00-549.00 (-4.59%)
2,851.05-96.35 (-3.27%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.